Atsushi Enomoto Selected Research

Microfilament Proteins (Actin Binding Proteins)

11/2020	Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells.
11/2018	Girdin/GIV regulates collective cancer cell migration by controlling cell adhesion and cytoskeletal organization.
8/2015	Potential involvement of kinesin-1 in the regulation of subcellular localization of Girdin.
1/2012	Involvement of Girdin in the determination of cell polarity during cell migration.
5/2011	The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury.
3/2008	An actin-binding protein Girdin regulates the motility of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Enomoto Research Topics

Disease

42	Neoplasms (Cancer) 04/2022 - 08/2004
9	Fibrosis (Cirrhosis) 10/2022 - 11/2010
5	Chronic Kidney Failure (Chronic Renal Failure) 11/2011 - 03/2003
5	Neuroblastoma 06/2011 - 08/2006
5	Renal hypouricemia 06/2005 - 09/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 10/2012
4	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2008
4	Glioma (Gliomas) 01/2019 - 10/2004
4	Schizophrenia (Dementia Praecox) 08/2015 - 09/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 09/2003
3	Leukemia 01/2017 - 10/2003
3	Endometrial Neoplasms (Endometrial Cancer) 07/2015 - 10/2009
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2012
2	Fibroma (Fibromatosis) 01/2022 - 06/2016
2	Hyperthermia 01/2022 - 10/2004
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2004
2	Lung Neoplasms (Lung Cancer) 12/2020 - 03/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2017
2	Myocardial Infarction 01/2019 - 11/2015
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2018 - 01/2018
2	Carcinogenesis 01/2018 - 04/2009
2	Lymphatic Metastasis 02/2016 - 03/2013
2	Vascular Remodeling 08/2014 - 05/2011
2	Chronic Renal Insufficiency 05/2014 - 01/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2012 - 10/2004
2	Kidney Diseases (Kidney Disease) 06/2011 - 07/2006
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2011 - 03/2003
2	Breast Neoplasms (Breast Cancer) 05/2008 - 03/2008
2	Hyperuricemia 06/2005 - 09/2003
2	Gout 06/2005 - 09/2003
1	Pruritus (Itching) 06/2022
1	Ascites 04/2022
1	Disease Progression 02/2022
1	Peritonitis 01/2022
1	Aggressive Fibromatosis (Desmoid) 01/2022
1	Colitis 01/2022
1	Insulinoma 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Systemic Scleroderma (Systemic Sclerosis) 12/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2021

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2004
8	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 04/2022 - 10/2012
7	IndicanIBA 05/2014 - 03/2003
6	Biological ProductsIBA 03/2022 - 07/2002
6	Pharmaceutical PreparationsIBA 02/2022 - 06/2005
6	Microfilament Proteins (Actin Binding Proteins)IBA 11/2020 - 03/2008
6	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 08/2004
6	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 06/2011 - 07/2005
5	Glycoproteins (Glycoprotein)IBA 04/2022 - 10/2012
5	CollagenIBA 01/2022 - 11/2015
5	Small Interfering RNA (siRNA)IBA 01/2018 - 08/2006
4	Uric Acid (Urate)IBA 06/2005 - 09/2003
3	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022 - 03/2013
3	AntibodiesIBA 12/2021 - 05/2008
3	RNA (Ribonucleic Acid)IBA 12/2021 - 03/2008
3	Collagen Type I (Type I Collagen)IBA 01/2021 - 07/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2014
3	IntegrinsIBA 05/2014 - 10/2009
3	AST 120IBA 05/2014 - 03/2003
3	Uremic ToxinsIBA 11/2010 - 07/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2010 - 07/2005
3	urate transporterIBA 02/2004 - 09/2003
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022 - 01/2021
2	tamibaroteneIBA 02/2022 - 01/2022
2	AutoantigensIBA 12/2021 - 03/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 12/2017
2	Serine (L-Serine)FDA Link 11/2015 - 05/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 02/2013
2	Cisplatin (Platino)FDA LinkGeneric 05/2014 - 04/2009
2	Complementary DNA (cDNA)IBA 03/2013 - 02/2004
2	DNA-Activated Protein KinaseIBA 09/2012 - 08/2004
2	GalactosidasesIBA 11/2011 - 11/2010
2	Formaldehyde (Formol)FDA Link 10/2009 - 05/2008
2	ParaffinIBA 10/2009 - 05/2008
2	CreatinineIBA 07/2006 - 01/2004
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 10/2004 - 08/2004
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2022
1	Interleukin-4 (Interleukin 4)IBA 06/2022
1	Interleukin-13IBA 06/2022
1	Histamine Antagonists (Antihistamines)IBA 06/2022
1	InterferonsIBA 05/2022
1	Gemcitabine FDA Link 02/2022
1	130-nm albumin-bound paclitaxelIBA 02/2022
1	Auranofin (Ridaura)FDA Link 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Thrombospondin 1IBA 01/2022
1	Bone Morphogenetic Protein 7IBA 01/2022
1	CalpainIBA 01/2022
1	Bromodeoxyuridine (BrdU)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	AntigensIBA 12/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	CytokinesIBA 12/2021
1	Small Cytoplasmic RNAIBA 12/2021

Therapy/Procedure

11	Therapeutics 01/2022 - 10/2004
2	Drug Therapy (Chemotherapy) 04/2022 - 10/2012
2	Radiotherapy 11/2021 - 07/2015
1	Molecular Targeted Therapy 01/2022